Blueprint JPM 2025 BPMC slides vF.pdf

1、Blueprint MedicinesDriving growth and innovation with operational excellenceKate Haviland,Chief Executive OfficerJ.P.Morgan Healthcare ConferenceJanuary 13,2025Forward-Looking StatementsThis presentation contains forward-looking statements within the meaning of the Private Securities Litigation Refo

2、rm Act of 1995,as amended,including,without limitation,statements regarding plans,strategies,timelines and expectations for the companys operations,including its growth strategies,opportunities and expectations for 2025 and beyond;the companys expectations regarding its estimated peak revenue for AY

3、VAKIT and the systemic mastocytosis market;continued growth in the breadth and depth of prescribing for AYVAKIT;the companys development plans and expectations regarding BLU-808,including its potential treatment for mast cell disorders,as well as other potential related allergic-inflammatory indicat

4、ions;expectations related to the markets for the companys current or future approved drugs and drug candidates,including expectations regarding the size or scale of patient opportunities that its current or future approved drugs and drug candidates;statements regarding anticipated clinical milestone

5、s;the potential benefits of any of the companys current or future approved drugs or drug candidates in treating patients;statements related to the companys liquidity and capital position,product revenues,run-rate,financial performance,strategy,goals and anticipated milestones,business plans and focu

6、s,including expectations regarding its 2025 capital allocation strategy,its anticipated cash burn,and path to profitability.The words“aim,”“may,”“will,”“could,”“would,”“should,”“expect,”“plan,”“anticipate,”“intend,”“believe,”“estimate,”“predict,”“project,”“potential,”“opportunity,”“continue,”“target